N-Phenylbenzamide

SCHEMBL6762152

CC(C)Cc1ccc(C(Nc2cccc(C(=O)c3cn(CCCC(=O)O)c4ccccc34)c2)c2ccc(CC(C)C)cc2)cc1.O=C(Nc1ccccc1)c1ccccc1

nearest known ligand 0.91

Predicted protein targets (top 13)

	gene	UniProt	supporting neighbours	confidence
▸	SRD5A1	P18405	6/20	0.91

▸	SRD5A2	P31213	6/20	0.91

▸	CNR1	P21554	4/20	0.45

▸	CNR2	P34972	3/20	0.45

▸	MAPT	P10636	3/20	0.42

▸	CREBBP	Q92793	2/20	0.41

▸	POLB	P06746	1/20	0.40

▸	SMN1; SMN2	Q16637	1/20	0.40

▸	THRB	P10828	1/20	0.40

▸	CPT2	P23786	1/20	0.39

▸	CPT1A	P50416	1/20	0.39

▸	CPT1B	Q92523	1/20	0.39

▸	PTGDR2	Q9Y5Y4	1/20	0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL29633452	0.95	SRD5A1 (1.00)	SRD5A1SRD5A2CNR1CNR2MAPT
SCHEMBL3504489	0.95	SRD5A1 (1.00)	SRD5A1SRD5A2CNR1CNR2MAPT
Hydrochloric Acid SCHEMBL8793978	0.95	SRD5A1 (0.98)	SRD5A1SRD5A2CNR1CNR2MAPT
SCHEMBL8793523	0.93	SRD5A1 (0.95)	SRD5A1SRD5A2CNR1CNR2MAPT
SCHEMBL9386762	0.91	SRD5A1 (0.91)	SRD5A1SRD5A2CNR1CNR2
SCHEMBL8792770	0.91	SRD5A1 (0.90)	SRD5A1SRD5A2CNR1CNR2MAPT
SCHEMBL8793385	0.89	SRD5A1 (0.88)	SRD5A1SRD5A2CNR1CNR2MAPT
SCHEMBL9335715	0.89	SRD5A1 (0.81)	SRD5A1SRD5A2CNR1CNR2MAPT
SCHEMBL9336300	0.88	SRD5A1 (0.86)	SRD5A1SRD5A2CNR1CNR2MAPT
SCHEMBL9337428	0.88	SRD5A1 (0.80)	SRD5A1SRD5A2CNR1CNR2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20040018991-A1	Topical treatment for mastalgia	MDI ONCOLOGY, INC.	2004-01-29	—	—	US	disclosed